| Announce Date | 12/10/2025 |
| EPS Normalized Actual | $-0.02 (Beat by $0.02) |
| EPS GAAP Actual | $-0.02 (Beat by $0.02) |
| Revenue Actual | $0B |
| Revenue Surprise | Beat by $0M |
| Announce Date | 01/31/2026 (Pre-Market) |
| EPS Normalized Estimate | $0.119 |
| EPS GAAP Estimate | $0.119 |
| Revenue Estimate | $0.000348B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Jul 2030 | 0.41 | 39.32 | 0.26008 | 0.5438 | 1 |
| Jul 2029 | 0.25 | 64.48 | 0.08627192 | 0.4438 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ4 2025 (Oct 2025) | -0.02 | -0.02 | 0B | -INF% | 0M |
| FQ3 2025 (Jul 2025) | -0.0607 | -0.0607 | 0B | NAN% | 0M |
| FQ2 2025 (Apr 2025) | -0.0703 | -0.0703 | 0B | NAN% | 0M |
| FQ1 2025 (Jan 2025) | -0.0242 | -0.0242 | 0.04975B | 99.77% | 49.75M |
| FQ4 2024 (Oct 2024) | -0.0489 | -0.0489 | 0.017087B | 99.37% | 17.09M |
| FQ3 2024 (Jul 2024) | 0 | 0 | 0B | -INF% | 0M |
| FQ2 2024 (Apr 2024) | -0.0532 | -0.0532 | 0B | NAN% | 0M |
| FQ1 2024 (Jan 2024) | 0.0056 | 0.0056 | 0.000116B | 100% | 0.12M |
FQ4 Announce Date
01/31/2026 (Pre-Market)
Consensus EPS Estimates
0.119
Consensus Revenue Estimates
0.000348B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ2 2028 (Apr 2028) | 0.1297 | -- | 0.1297 | 0.1297 | 0 |
| FQ1 2028 (Jan 2028) | 0.1297 | -- | 0.1297 | 0.1297 | 0 |
| FQ4 2027 (Oct 2027) | 0.1297 | -- | 0.1297 | 0.1297 | 0 |
| FQ3 2027 (Jul 2027) | 0.1159 | -- | 0.1159 | 0.1159 | 0 |
| FQ2 2027 (Apr 2027) | 0.1206 | -- | 0.1206 | 0.1206 | 0 |
| FQ1 2027 (Jan 2027) | 0.1371 | -- | 0.1371 | 0.1371 | 0 |
| FQ4 2026 (Oct 2026) | 0.1248 | 116.03 | 0.1248 | 0.1248 | 0 |
| FQ3 2026 (Jul 2026) | 0.0836 | 172.61 | 0.0836 | 0.0836 | 0 |
| FQ2 2026 (Apr 2026) | 0.0947 | 174.23 | 0.0947 | 0.0947 | 0 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ2 2028 (Apr 2028) | 0B | -- | 0B | 0B | 0 |
| FQ1 2028 (Jan 2028) | 0B | -- | 0B | 0B | 0 |
| FQ4 2027 (Oct 2027) | 0B | -- | 0B | 0B | 0 |
| FQ3 2027 (Jul 2027) | 0B | -- | 0B | 0B | 0 |
| FQ2 2027 (Apr 2027) | 0B | -- | 0B | 0B | 0 |
| FQ1 2027 (Jan 2027) | 0B | -- | 0B | 0B | 0 |
| FQ4 2026 (Oct 2026) | 0B | -- | 0B | 0B | 0 |
| FQ3 2026 (Jul 2026) | 0B | -- | 0B | 0B | 0 |
| FQ2 2026 (Apr 2026) | 0B | -- | 0B | 0B | 0 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
1
EPS # of Misses
6
EPS # of in-lines
1
Revenue # of Beats
3
Revenue # of Misses
0
Revenue # of in-lines
5
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Oct 2025) | -0.02 | -0.02 | 100% | |
| FQ3 2025 (Jul 2025) | -0.0607 | -0.0607 | 100% | |
| FQ2 2025 (Apr 2025) | -0.0703 | -0.0703 | 100% | |
| FQ1 2025 (Jan 2025) | -0.0242 | -0.0242 | 100% | |
| FQ4 2024 (Oct 2024) | -0.0489 | -0.0489 | 100% | |
| FQ3 2024 (Jul 2024) | 0 | 0 | NAN% | |
| FQ2 2024 (Apr 2024) | -0.0532 | -0.0532 | 100% | |
| FQ1 2024 (Jan 2024) | 0.0056 | 0.0056 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Oct 2025) | $0B | $0B | $0M | NAN% |
| FQ3 2025 (Jul 2025) | $0B | $0B | $0M | NAN% |
| FQ2 2025 (Apr 2025) | $0B | $0B | $0M | NAN% |
| FQ1 2025 (Jan 2025) | $0B | $0.05B | $49.75M | 100% |
| FQ4 2024 (Oct 2024) | $0B | $0.02B | $17.09M | 100% |
| FQ3 2024 (Jul 2024) | $0B | $0B | $0M | NAN% |
| FQ2 2024 (Apr 2024) | $0B | $0B | $0M | NAN% |
| FQ1 2024 (Jan 2024) | $0B | $0B | $0.12M | 100% |